PAPER Khan W, Amad A, Giampietro V, Werden E, De Simoni S, O'Muircheartaigh J, Westman E, O'Daly O, Williams SC, Brodtmann A, Alzheimer's Disease Neuroimaging Initiative
PAPER Ramzan F, Khan MU, Rehmat A, Iqbal S, Saba T, Rehman A, Mehmood Z
A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks.J Med Syst. 2019 Dec 18;44(2):37. PubMed: 31853655
PAPER Lehallier B, Gate D, Schaum N, Nanasi T, Lee SE, Yousef H, Moran Losada P, Berdnik D, Keller A, Verghese J, Sathyan S, Franceschi C, Milman S, Barzilai N, Wyss-Coray T31806903
PAPER Nicholls SJ, Puri R, Wolski K, Ballantyne CM, Barter PJ, Brewer HB, Kastelein JJ, Hu B, Uno K, Kataoka Y, Herrman JP, Merkely B, Borgman M, Nissen SE
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.Am J Cardiovasc Drugs. 2016 Feb;16(1):55-65. PubMed: 26385396
CONFERENCE COVERAGE 2019-12-20 Conference Coverage Anti-amyloid antibodies are at long last showing promise for treating Alzheimer’s disease, but for long-term use, researchers are seeking cheaper and easier options than monthly infusions. They want that elusive once-a-day pill. BACE ...
University of Maryland School of MedicineBaltimore
CONFERENCE COVERAGE 2019-12-20 Conference Coverage With aducanumab’s resurrection driving renewed interest in anti-amyloid antibody therapies, researchers at the 12th Clinical Trials on Alzheimer’s Disease conference, held December 4–7 in San Diego, happily provided updates on their ...
Dietmar Thal, Luís Aragão Gomes on Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease.
COMMENT During the last years, we have seen growing evidence that cooperation between pathological proteins may be a key element in the pathogenesis of a variety of neurodegenerative diseases, with the most recent example being a study showing accelerated ...
PAPER Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, Asfaw A, Hall TC, Ding L, DeSousa A, Frosch MP, Collinge J, Harris DA, Perkinton MS, Spires-Jones TL, Young-Pearse TL, Billinton A, Walsh DM
PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.Acta Neuropathol. 2020 Mar;139(3):503-526. Epub 2019 Dec 18 PubMed: 31853635
Delft University of Technology Netherlands
PAPER Schaeverbeke J, Celen S, Cornelis J, Ronisz A, Serdons K, Van Laere K, Thal DR, Tousseyn T, Bormans G, Vandenberghe R
Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients.Eur J Nucl Med Mol Imaging. 2019 Dec 18; PubMed: 31848674
PAPER Schmitz M, Candelise N, Kanata E, Llorens F, Thüne K, Villar-Piqué A, da Silva Correia SM, Dafou D, Sklaviadis T, Appelhans D, Zerr I31848935
PAPER Ma WY, Yao Q, Hu GJ, Xiao CY, Shi JP, Chen J31849824
PAPER Wagenbreth C, Kuehne M, Heinze HJ, Zaehle T